Atria Investments’s iShares Investment Grade Systematic Bond ETF IGEB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$360K Buy
7,986
+375
+5% +$16.9K ﹤0.01% 1726
2026
Q1
$343K Sell
7,611
-34,754
-82% -$1.58M ﹤0.01% 1667
2025
Q4
$1.93M Sell
42,365
-50
-0.1% -$2.29K 0.02% 736
2025
Q3
$1.95M Sell
42,415
-6,211
-13% -$283K 0.02% 731
2025
Q2
$2.21M Buy
48,626
+1,673
+4% +$74.5K 0.03% 684
2025
Q1
$2.11M Buy
46,953
+14,470
+45% +$646K 0.03% 679
2024
Q4
$1.44M Sell
32,483
-30,734
-49% -$1.39M 0.02% 820
2024
Q3
$2.94M Buy
63,217
+3,577
+6% +$163K 0.04% 541
2024
Q2
$2.65M Buy
59,640
+28,276
+90% +$1.25M 0.03% 546
2024
Q1
$1.41M Buy
+31,364
New +$1.4M 0.02% 795

Other funds holding IGEB

Atria Investments's IGEB Position: Q2 2026 in Review

Atria Investments increased its iShares Investment Grade Systematic Bond ETF (IGEB) stake by 4.9% in Q2 2026, buying an estimated $16.9K and bringing the position to 7,986 shares worth $360K. The position accounts for ﹤0.01% of the portfolio, ranked #1726.

Atria Investments first reported a position in IGEB in Q1 2024 and has held it in 10 quarters since. The position peaked at $2.94M in Q3 2024. 189 funds tracked by Wall St. Rank hold IGEB as of Q2 2026.

  • Atria Investments held 7,986 shares of iShares Investment Grade Systematic Bond ETF worth $360K as of Q2 2026.
  • Atria Investments bought 375 iShares Investment Grade Systematic Bond ETF shares in Q2 2026, an estimated $16.9K.
  • iShares Investment Grade Systematic Bond ETF made up ﹤0.01% of Atria Investments's portfolio in Q2 2026, its #1726 holding.
  • Atria Investments first reported a position in iShares Investment Grade Systematic Bond ETF in Q1 2024 and has held it in 10 quarters since.
  • Atria Investments's iShares Investment Grade Systematic Bond ETF position peaked at $2.94M in Q3 2024.
  • 189 funds tracked by Wall St. Rank held iShares Investment Grade Systematic Bond ETF as of Q2 2026.

Based on Atria Investments's 13F filing for Q2 2026, filed 28 Jul 2026.